Arvelle Therapeutics

Showing 1 posts of 1 posts found.

EMA recommends Arvelle’s seizure drug cenobamate

February 2, 2021
Manufacturing and Production Arvelle Therapeutics, epilepsy

The EMA has recommended the approval of Arvelle Therapeutics’ cenobamate for the adjunctive treatment of focal onset seizures with or …

Latest content